Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, F. H.
Right arrow Articles by Fallat, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, F. H.
Right arrow Articles by Fallat, R. J.
NEUROLOGY 1986;36:1263
© 1986 American Academy of Neurology

Trial of octacosanol in amyotrophic lateral sclerosis

Forbes H. Morris, MD, Eric H. Denys, MD and Robert J. Fallat, MD

ALS Center and the Departments of Neurology and Medicine (Pulmonary Service), Pacific Presbyterian Medical Center, San Francisco, CA.

Octacosanol was tried in amyotrophic lateral sclerosis in a double-blind, placebo-controlled, crossover design. Neurologic and pulmonary function evaluations showed no benefit.

Address correspondence and reprint requests to Dr. Norris, ALS Center, Pacific Presbyterian Medical Center, PO Box 7999, San Francisco, CA 94120.

Supported by the East Bay, Hayward (Sons of Italy), and South Bay (Quement) Chapters of the ALS and Neuromuscular Research Foundation.

Accepted for publication January 3, 1986.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.